FIGS, Inc. · Consumer Discretionary · Apparel Manufacturing
Scores & Status Key
AI Summary Scores: Intraday / Swing / Long scores are synthesized from multi-factor analysis for each timeframe. They summarize current conditions discussed in the report and do not constitute trading recommendations.
Intraday Trend Score: A 0–100 composite from the Trend Explorer™ analytics engine used for ranking and comparison. It describes current conditions and is not a forecast.
Trend Status: A rules-based label (Bullish / Mixed / Bearish) derived from signal confluence (trend structure, momentum, and positioning). It indicates alignment, not expected return.
Last
$19.05
−$0.49 (−2.50%) 3:58 PM ET
Prev closePrevC$19.54
OpenOpen$19.77
Day highHigh$20.27
Day lowLow$18.68
VolumeVol4,051,403
Avg volAvgVol3,634,449
On chart
Interval
Intervals apply to 1D & 5D.
Intervals apply to 1D & 5D.
Scale: Linear
Overlays
Panels
Style
Scale: Linear
Presets
Tools
Tickers only (no ^ indexes). Add up to 5.
Mkt cap
$3.10B
EV/Sales
4.21
P/E ratio
49.99
FY Revenue
$710.08M
EPS
0.37
Gross Margin
68.91%
Div yield
0.00%
Sector
Consumer Discretionary
AI report sections
MIXED
FIGS
FIGS, Inc.
No AI report section text found yet for this symbol.
Domino's Q3 Earnings & Revenues Top Estimates on Supply Chain Strength
Domino's Pizza reported Q3 2026 earnings of $4.60 per share, beating estimates by 6.2%, with revenues of $1.19 billion topping consensus. Supply chain revenues grew 7.1% to $746.2 million driven by higher order volumes and pricing. However, same-store sales growth slowed significantly, with U.S. franchise comps rising just 0.3% versus 5.3% year-ago, while international comps grew only 0.2%. The company added 175 net stores globally and maintained capital return programs through dividends and share buybacks.
Rated Zacks Rank #2 (Buy) with strong 201.8% average earnings surprise and positive growth projections (19.8% sales, 89.5% EPS), but stock has declined 39.8% year-to-date, indicating market skepticism despite fundamental strength.
PositiveZacks Investment Research• Na
Figs (FIGS) Is Up 16.72% in One Week: What You Should Know
Figs Inc., a healthcare apparel company, demonstrates strong momentum characteristics with a Zacks Momentum Style Score of B and a Zacks Rank #2 (Buy) rating. The stock has surged 16.72% over the past week and 150.21% over the past year, significantly outperforming the S&P 500. Recent earnings estimate revisions have been positive, with consensus estimates increasing from $0.32 to $0.36 in the past 60 days, supporting the bullish outlook.
Strong short-term and long-term price performance (16.72% weekly, 150.21% yearly), outperforming industry and S&P 500 benchmarks. Positive earnings estimate revisions over the past 60 days with upward momentum continuing into the next fiscal year. Zacks Rank #2 (Buy) with Momentum Style Score of B indicates favorable near-term prospects.
FIGS, Inc. reported robust second-quarter 2026 results with active customers rising 13.2% to 3.1 million and revenue per customer hitting a record $229. Scrubwear sales grew 26.5% while non-scrubwear revenues jumped 40.3%, driven by product innovation and repeat purchases. The company raised its full-year revenue growth outlook to approximately 20%, marking its third consecutive quarter of growth above 25%.
FIGSGCODBIURBNhealthcare apparelcustomer growthrevenue per customerproduct innovation
Sentiment note
Strong quarter with 28.8% revenue growth, 13.2% active customer growth, record revenue per customer of $229, improved purchase frequency, and raised full-year guidance to ~20% growth. Stock up 82.5% in three months. Zacks Rank #2 (Buy) with positive earnings revisions.
PositiveThe Motley Fool• Emma Newbery
Stock Market Today, Oct. 12: Dow Gains as Memory Stocks Weigh on Nasdaq
On October 12, 2026, the Dow Jones rose 0.38% while the S&P 500 and Nasdaq declined as investors rotated into value sectors away from technology. Memory chip stocks and semiconductor names faced pressure amid valuation concerns, while Meta Platforms gained on its new AI model launch and Figs surged over 12%. Bank earnings and inflation data are expected this week.
Healthcare apparel stock surged over 12% and is up over 30% in the past five days, attracting investor attention
PositiveZacks Investment Research• Na
Zumiez's Private Label and Product Newness Help Sustain Global Gains
Zumiez (ZUMZ) is pursuing international growth through private-label expansion and distinctive merchandise while addressing weakness in its U.S. business. Europe and Australia net sales rose 2.5% to $35.1 million in Q2 fiscal 2026. The company is implementing premium pricing and expense management to improve margins, though shares have declined 20.4% in three months and the stock trades at a premium valuation of 19.25x forward P/E versus the industry average of 12.97x.
FIGS carries a Zacks Rank #2 (Buy) with strong consensus estimates showing 19.8% sales growth and 89.5% earnings growth for the current fiscal year. The company has delivered an impressive trailing four-quarter earnings surprise of 201.8% on average, indicating consistent outperformance.
PositiveZacks Investment Research• Na
Here's Why Figs (FIGS) is a Strong Momentum Stock
Zacks Premium offers investment research tools including Style Scores (Value, Growth, Momentum, and VGM) that work alongside the Zacks Rank system to help investors identify high-performing stocks. The article highlights FIGS, Inc. as a stock to watch with a #2 Buy rating and B VGM Score, noting recent upward earnings revisions and strong momentum.
FIGS received a #2 (Buy) Zacks Rank with a B VGM Score. The company showed strong momentum with shares up 18.2% over four weeks, two upward earnings revisions in the last 60 days, and an exceptional average earnings surprise of +201.8%, making it a recommended stock to watch.
PositiveZacks Investment Research• Na
Figs (FIGS) Soars 6.5%: Is Further Upside Left in the Stock?
Figs (FIGS) shares rose 6.5% to $14.98 on strong volume, supported by positive earnings expectations of $0.07 per share (+40% YoY) and revenue growth of 19.5%. The company benefits from strong customer engagement, product innovation, and expanding international operations. Earnings estimate revisions have been revised 1.2% higher over the past month, suggesting continued momentum. The stock carries a Zacks Rank #2 (Buy) rating.
Stock gained 6.5% on strong volume with positive earnings expectations (+40% YoY), revenue growth of 19.5%, upward earnings estimate revisions (+1.2%), and strong operational fundamentals including customer engagement and product innovation. Zacks Rank #2 (Buy) rating supports positive outlook.
PositiveZacks Investment Research• Na
GAP Stock Climbs 25% in 3 Months: Can Growth Momentum Last?
Gap Inc. (GAP) shares surged 25.3% over three months, outperforming the retail sector, driven by strong performance at its Gap and Banana Republic brands, improved merchandise margins, and disciplined inventory management. The company raised its FY26 adjusted EPS outlook to $2.35-$2.45 despite ongoing challenges at Old Navy and Athleta. Gap brand achieved its 11th consecutive quarter of positive comparable sales growth with a 10% increase in Q2, while the stock trades at an attractive 9.22X forward P/E multiple.
Carries Zacks Rank #2 (Buy) with consensus estimates implying 19.8% sales growth and 89.5% earnings growth. Delivered exceptional trailing four-quarter earnings surprise of 201.8% on average, demonstrating strong operational execution.
PositiveZacks Investment Research• Na
FIGS' Pricing Strategy Supports Higher Order Values & Full-Price Sales
FIGS Inc. reported record average order value of $127 (up 9%) driven by pricing actions and reduced discounting. Active customers grew 13% to 3.1 million with revenue per customer reaching a record $229. The company raised its 2026 revenue growth outlook to approximately 20% and adjusted EBITDA margin guidance to 14.8-15%. Scrubwear revenues grew 27% while non-scrubwear sales increased 40%.
FIGSGCODBIURBNFIGS Inc.average order valuepricing strategycustomer growth
Sentiment note
FIGS demonstrated strong operational performance with record average order value and customer metrics. The company raised full-year 2026 revenue growth guidance to ~20% and EBITDA margin guidance to 14.8-15%. Stock has surged 104.4% over the past year, and the company carries a Zacks Rank #2 (Buy) with upward earnings estimate revisions.
PositiveZacks Investment Research• Zacks.Com
Wall Street Analysts Believe Figs (FIGS) Could Rally 28.44%: Here's is How to Trade
Wall Street analysts have set a mean price target of $18.11 for Figs (FIGS), suggesting a potential 28.4% upside from its current price of $14.10. The stock has gained 3.1% over the past four weeks and holds a Zacks Rank #2 (Buy) rating. Analysts have revised earnings estimates upward by 6% over the last 30 days, indicating growing optimism about the company's earnings prospects.
Mean analyst price target of $18.11 indicates 28.4% upside potential; Zacks Rank #2 (Buy) rating places it in top 20% of stocks; positive earnings estimate revisions (6% increase over 30 days with 2 upward revisions and no negative revisions); recent 3.1% gain over four weeks demonstrates positive momentum.
PositiveZacks Investment Research• Na
Can Zumiez's Data-Driven Marketing Improve Customer Engagement?
Zumiez (ZUMZ) is using data analytics to improve customer insights and marketing effectiveness while working to enhance customer experience through operational changes. However, the company faces headwinds from U.S. sales deceleration driven by footwear softness and declining transactions. Management views the downturn as temporary and is refining merchandise assortments to navigate this transitional period.
Zacks Rank #2 (Buy) with strong growth expectations: 19.8% sales growth and 89.5% earnings growth projected for current fiscal year. Exceptional trailing four-quarter earnings surprise of 201.8% on average demonstrates consistent outperformance.
PositiveZacks Investment Research• Na
Dollar Tree's Comp Trend Improves: What's Fueling Growth Now?
Dollar Tree reported Q2 comparable-store sales growth of 3.7%, driven by a 3.3% increase in average ticket and 0.4% rise in traffic. The company expects full-year comp sales growth of 3%-4%, with multi-price penetration reaching 17% of sales. Management believes improved assortments, store standards, and marketing can sustain traffic growth in the second half, though higher freight costs and merchandise inflation could pressure profitability.
Healthcare apparel company with Zacks Rank #2 (Buy) showing strong consensus estimates for current fiscal year with 89.5% earnings growth and 19.8% sales growth. Delivered exceptional trailing four-quarter average earnings surprise of 201.8%.
News and sentiment labels describe article tone and are provided for research purposes only. They are not trading recommendations or forecasts.
Trade Ranks App
Trade Ranks, LLC is not a registered investment adviser or broker-dealer. All rankings and AI reports are for informational and educational purposes only and are not personalized advice. Investing involves risk. Policy Portal